531633 — LINCOLN PHARMACEUTICALS Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹12.00bn
- IN₹10.25bn
- IN₹5.10bn
- 92
- 38
- 83
- 87
Annual cashflow statement for LINCOLN PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 622 | 672 | 837 | 959 | 1,005 |
| Depreciation | |||||
| Non-Cash Items | 25.9 | 6.72 | -24.6 | -58.8 | -85.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -186 | 1.84 | -196 | -220 | -618 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 528 | 754 | 693 | 761 | 393 |
| Capital Expenditures | -149 | -76.9 | -87.5 | -455 | -143 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -32.5 | -232 | -555 | -326 | -224 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -182 | -309 | -642 | -781 | -366 |
| Financing Cash Flow Items | -44.7 | -19.9 | -11.9 | -10.4 | -13.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -358 | -378 | -57.5 | -25.6 | -45 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -11.1 | 67.7 | -7.03 | -45 | -18.8 |